CITIGROUP INC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$2,000
-97.1%
1,752
-95.4%
0.00%
Q2 2022$68,000
-82.2%
37,715
-80.0%
0.00%
Q1 2022$382,000
-86.2%
188,919
-81.5%
0.00%
-100.0%
Q4 2021$2,765,000
+33.8%
1,020,351
+120.2%
0.00%0.0%
Q3 2021$2,066,000
-48.4%
463,330
-32.8%
0.00%
-50.0%
Q2 2021$4,001,000
-17.3%
689,759
+0.1%
0.00%
-33.3%
Q1 2021$4,839,000
+373.0%
689,258
+223.4%
0.00%
Q4 2020$1,023,000
-23.7%
213,104
-7.3%
0.00%
Q3 2020$1,340,000
-39.1%
229,846
-29.5%
0.00%
-100.0%
Q2 2020$2,201,000
+39.7%
325,936
+31.7%
0.00%0.0%
Q1 2020$1,575,000
-48.4%
247,557
-15.4%
0.00%
-66.7%
Q4 2019$3,051,000
+279.5%
292,596
+43.1%
0.00%
Q3 2019$804,000
-88.1%
204,480
-55.0%
0.00%
-100.0%
Q2 2019$6,761,000
+247.6%
454,702
+480.3%
0.01%
+200.0%
Q1 2019$1,945,000
-74.6%
78,355
-81.6%
0.00%
-75.0%
Q4 2018$7,656,000
+73.6%
426,301
+183.8%
0.01%
+100.0%
Q3 2018$4,411,000
+67.8%
150,191
+159.7%
0.00%
+100.0%
Q2 2018$2,629,000
-73.8%
57,828
-69.6%
0.00%
-77.8%
Q1 2018$10,049,000
+6.4%
190,324
+37.0%
0.01%
+28.6%
Q4 2017$9,448,000
-69.5%
138,943
-63.1%
0.01%
-72.0%
Q3 2017$30,988,000
-9.3%
376,073
+3.1%
0.02%
-19.4%
Q2 2017$34,150,000
+9.2%
364,743
-25.7%
0.03%
+14.8%
Q1 2017$31,261,000
+137.7%
490,999
+65.9%
0.03%
+125.0%
Q4 2016$13,150,000
+363.5%
296,042
+276.1%
0.01%
+300.0%
Q3 2016$2,837,000
+839.4%
78,715
+258.7%
0.00%
Q2 2016$302,000
-88.9%
21,942
-84.5%
0.00%
-100.0%
Q1 2016$2,718,000
-22.5%
141,577
+41.4%
0.00%0.0%
Q4 2015$3,505,000
-75.6%
100,155
-35.8%
0.00%
-78.6%
Q3 2015$14,347,000
+246.4%
156,012
+230.9%
0.01%
+250.0%
Q2 2015$4,142,000
+64.7%
47,141
+39.2%
0.00%
+100.0%
Q1 2015$2,515,000
+93.3%
33,875
+45.8%
0.00%
+100.0%
Q4 2014$1,301,000
+29.3%
23,231
+4.8%
0.00%0.0%
Q3 2014$1,006,000
+54.8%
22,166
+41.2%
0.00%
Q2 2014$650,000
+13.4%
15,699
+89.4%
0.00%
-100.0%
Q1 2014$573,000
-12.9%
8,288
-24.0%
0.00%0.0%
Q4 2013$658,000
+0.9%
10,902
+1.7%
0.00%0.0%
Q3 2013$652,000
+3004.8%
10,715
+3269.5%
0.00%
Q2 2013$21,0003180.00%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders